A股异动 | 中核钛白涨逾4% 拟入股锦泰钾肥 为磷酸铁锂项目铺路
格隆汇11月30日丨中核钛白涨逾4%,报14.01元,总市值288亿元。中核钛白昨晚公吿称,公司与锦泰钾肥、李世文及富康矿业分别签署了《关于青海锦泰钾肥有限公司增资协议》和《购销战略合作框架协议》。两份协议标志着中核钛白为旗下磷酸铁锂项目所需碳酸锂材料采购铺路。根据相关增资协议,中核钛白拟以自有资金向锦泰钾肥增资2亿元,其中889万元为锦泰钾肥新增的注册资本,其余部分计入锦泰钾肥的资本公积。交易完成后,公司将持有锦泰钾肥4.39%的股权。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.